GSK plc (BCBA:GSK)
Argentina
· Delayed Price · Currency is ARS 12,175
+25 (0.21%)
At close: Jul 8, 2025, 5:00 PM BRT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
HIV | 7.09B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
HIV Growth | 9.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -30.77B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 5.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Meningitis | 1.44B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Meningitis Growth | 16.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Influenza | 408.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Influenza Growth | -21.58% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Established Vaccines | 3.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Established Vaccines Growth | 0.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Shingles | 3.36B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Shingles Growth | -7.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oncology | 1.41B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oncology Growth | 78.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Respiratory, Immunology and Inflammation | 3.30B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Respiratory, Immunology and Inflammation Growth | 13.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Respiratory | 7.21B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Respiratory Growth | 6.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other General Medicines | 3.22B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other General Medicines Growth | -5.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Commerical Operations | 31.38B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Commerical Operations Growth | 2.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Consumer Healthcare | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pandemic | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pandemic Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pandemic Vaccines | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pandemic Vaccines Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -30.77B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 5.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | -3.31B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 349.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Commercial Operations Segment Profit | 15.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Commercial Operations Segment Profit Growth | 1.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Research & Development Segment Profit | -5.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Research & Development Segment Profit Growth | 3.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consumer Healthcare Segment Profit | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -3.31B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 349.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
US Revenue | 16.38B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
US Revenue Growth | 2.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 6.67B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | 4.83% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International | 8.33B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Growth | 0.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|